Viva Biotech's 15-Year Commitment to European Drug Discovery and Collaboration Celebrating 15 years of collaboration, Viva Biotech strengthens bonds with Europe's drug discovery community, fostering innovation and reliability in biopharmaceuticals.

Viva Biotech's 15-Year Commitment to European Drug Discovery and Collaboration #China #Shanghai #biopharmaceuticals #Drug_Discovery #Viva_Biotech

Zeureka and Sumitomo Pharma Collaborate on Molecule Drug Discovery Research Zeureka and Sumitomo Pharma have signed a research agreement to work on low-molecular drug discovery, aiming to innovate new pharmaceutical candidates together.

Zeureka and Sumitomo Pharma Collaborate on Molecule Drug Discovery Research #Japan #Tokyo #Drug_Discovery #Sumitomo_Pharma #Zeureka

DeuteRx Honors Women's History Month with Years of Innovation in Drug Discovery DeuteRx, celebrating Women's History Month, showcases over a decade of leadership from Dr. Sheila DeWitt in advancing drug discovery innovation.

DeuteRx Honors Women's History Month with Years of Innovation in Drug Discovery #USA #Boston #Drug_Discovery #DeuteRx #Sheila_DeWitt

Viva Biotech's 2025 Annual Report Highlights AI Advancements in Drug Discovery and CDMO Growth Viva Biotech recently announced impressive 2025 annual results highlighting significant advancements in AI-driven drug discovery and CDMO product scaling.

Viva Biotech's 2025 Annual Report Highlights AI Advancements in Drug Discovery and CDMO Growth #China #Shanghai #Drug_Discovery #CDMO #Viva_Biotech

Building a Drug Discovery Ecosystem: Seminar on Clinical Trials and Regulations in Japan Join us for a pivotal seminar on Japan's drug discovery ecosystem featuring insights from the Ministry of Health, Labour and Welfare. Explore innovative strategies and clinical trial advancements.

Building a Drug Discovery Ecosystem: Seminar on Clinical Trials and Regulations in Japan #Japan #Tokyo #Clinical_Trials #Drug_Discovery #JPI_Seminar

Our team is currently attending the #MAINFRAME_Symposium, presenting several #posters that showcase our latest work in #computational_science & #drug_discovery.
We are incredibly proud of their dedication to advancing the field, right here in our home city! 🚀

🔗 event.fourwaves.com/mainframesym...

Dalriada Drug Discovery and Topos Bio Unite for Advanced Drug Discovery on Intrinsically Disordered Proteins Dalriada Drug Discovery and Topos Bio have joined forces to enhance drug discovery efforts for intrinsically disordered proteins, leveraging advanced mass spectrometry technologies.

Dalriada Drug Discovery and Topos Bio Unite for Advanced Drug Discovery on Intrinsically Disordered Proteins #USA #San_Francisco #Drug_Discovery #Dalriada #Topos_Bio

Viva Biotech's Innovations in AI-Driven Drug Discovery with NVIDIA Technology Viva Biotech is leveraging NVIDIA technology to revolutionize drug discovery with AI, optimizing designs for improved outcomes in therapeutics and biological research.

Viva Biotech's Innovations in AI-Driven Drug Discovery with NVIDIA Technology #China #Shanghai #NVIDIA #Drug_Discovery #Viva_Biotech

Viva Biotech Partners with NVIDIA to Boost AI-Driven Drug Discovery Efforts Viva Biotech has teamed up with NVIDIA to enhance its innovative drug discovery process through AI. This collaboration aims to revolutionize the development of targeted therapeutics.

Viva Biotech Partners with NVIDIA to Boost AI-Driven Drug Discovery Efforts #China #Shanghai #NVIDIA #Drug_Discovery #Viva_Biotech

PRISM BioLab and Receptor.AI's Collaboration to Transform Drug Discovery Processes The partnership between PRISM BioLab and Receptor.AI to enhance drug discovery through advanced AI integration shows great promise in targeting complex diseases.

PRISM BioLab and Receptor.AI's Collaboration to Transform Drug Discovery Processes #Japan #Tokyo #Drug_Discovery #PRISM_BioLab #Receptor.AI

The Third Annual Bio-IT World Venture Conference is Back in Boston on May 19, 2026 The Bio-IT World Venture, Innovation & Partnering Conference returns to Boston on May 19, 2026, connecting leaders in life sciences to accelerate drug discovery.

The Third Annual Bio-IT World Venture Conference is Back in Boston on May 19, 2026 #United_States #Boston #Drug_Discovery #Bio-IT_World #Cambridge_Healthtech

Mark Foundation Awards $4 Million to Advance Cancer Drug Discovery in 2026 The Mark Foundation has announced the recipients of the 2026 Drug Discovery Awards, providing $4 million to support breakthrough cancer research.

Mark Foundation Awards $4 Million to Advance Cancer Drug Discovery in 2026 #USA #New_York #Cancer_Research #Drug_Discovery #Mark_Foundation

Innovative Partnership Between Insilico Medicine and Liquid AI Enhances Drug Discovery with Lightweight Models Insilico Medicine and Liquid AI have teamed up to develop innovative lightweight models for drug discovery, aiming to streamline pharmaceutical research while maintaining data security.

Innovative Partnership Between Insilico Medicine and Liquid AI Enhances Drug Discovery with Lightweight Models #USA #Cambridge #Drug_Discovery #Insilico_Medicine #Liquid_AI

Flare Therapeutics Enhances Drug Discovery with Simplicis Partnership for Inventory Management Flare Therapeutics joins forces with Simplicis to improve compound management, eliminating risks associated with manual data oversight in drug discovery processes.

Flare Therapeutics Enhances Drug Discovery with Simplicis Partnership for Inventory Management #USA #Cambridge #Flare_Therapeutics #Drug_Discovery #Simplicis

IRBM Announces Major Breakthrough in Zika Virus Drug Discovery IRBM has made significant progress in developing a new therapeutic approach against the Zika virus. The discovery of a potent allosteric inhibitor represents hope for effective treatments.

IRBM Announces Major Breakthrough in Zika Virus Drug Discovery #Italy #Drug_Discovery #Rome #IRBM #Zika_Virus

IRBM Achieves Milestone in Developing Zika Virus Treatment with New Drug Discovery IRBM has made significant progress in combating the Zika virus with a novel drug discovery, offering new hope for antiviral treatments and public health.

IRBM Achieves Milestone in Developing Zika Virus Treatment with New Drug Discovery #USA #Drug_Discovery #Rome #IRBM #Zika_Virus

Proteomics Market Projected to Reach $58.66 Billion by 2031: Insight from the Latest Mordor Intelligence Report The proteomics market is anticipated to grow significantly, reaching $58.66 billion by 2031, driven by advances in precision medicine and drug discovery.

Proteomics Market Projected to Reach $58.66 Billion by 2031: Insight from the Latest Mordor Intelligence Report #India #Precision_Medicine #Drug_Discovery #Hyderabad #Proteomics_Market

Insilico Medicine Launches the Science MMAI Gym: A New Era in Drug Discovery Technologies Insilico Medicine introduces the Science MMAI Gym to enhance AI-driven drug discovery, improving LLM performance significantly for pharmaceutical applications.

Insilico Medicine Launches the Science MMAI Gym: A New Era in Drug Discovery Technologies #United_States #Cambridge #Drug_Discovery #Insilico_Medicine #Science_MMAI_Gym

Harnessing AI for Efficient RNA Aptamer Drug Discovery with RaptScore Technology Discover how RaptScore, an innovative AI technology developed at Waseda University, accelerates RNA aptamer drug discovery by accurately evaluating binding activity.

Harnessing AI for Efficient RNA Aptamer Drug Discovery with RaptScore Technology #Japan #Tokyo #Drug_Discovery #RNA_Aptamer #RaptScore

Exploring the Growth of Drug Discovery Technologies Market Forecasted to Reach Over $51 Billion by 2031 The Drug Discovery Technologies Market is set to grow significantly, reaching an estimated USD 51.51 billion by 2031, driven by advancements like high-throughput screening and AI integration.

Exploring the Growth of Drug Discovery Technologies Market Forecasted to Reach Over $51 Billion by 2031 #USA #Delray_Beach #MarketsandMarkets #biotechnology #Drug_Discovery

Converge Bio Secures $25 Million Funding to Revolutionize Drug Discovery with Generative AI Converge Bio has raised $25 million in Series A funding to enhance drug discovery in biotechs and pharmaceutical companies with AI innovation.

Converge Bio Secures $25 Million Funding to Revolutionize Drug Discovery with Generative AI #USA #Generative_AI #Boston #Drug_Discovery #Converge_Bio

Exploring AI Trends Shaping Drug Discovery and R&D Investments at Fierce JPM Week AlphaSense will discuss the impact of AI on drug discovery and R&D investments at the Fierce JPM Week Conference, featuring key insights from industry leaders.

Exploring AI Trends Shaping Drug Discovery and R&D Investments at Fierce JPM Week #USA #New_York #Drug_Discovery #AlphaSense #Fierce_JPM

M&G Leads $50 Million Funding Round for Biotech Innovator bit.bio in UK Drug Development M&G Investments has led a $50 million funding for Cambridge-based bit.bio, enhancing UK innovation in drug discovery with human cell technology.

M&G Leads $50 Million Funding Round for Biotech Innovator bit.bio in UK Drug Development #Cambridge #United_Kingdom #Drug_Discovery #bit.bio #M&G_Investments

M&G Investment Leads $50 Million Funding Round for Biotech Firm bit.bio to Innovate Drug Discovery M&G Investments spearheads a $50 million funding initiative for bit.bio, the UK biotech company revolutionizing drug discovery with human cell technology.

M&G Investment Leads $50 Million Funding Round for Biotech Firm bit.bio to Innovate Drug Discovery #Cambridge #United_Kingdom #Drug_Discovery #bit.bio #M&G_Investments

Variant Bio Unveils Inference: A Revolutionary AI Genomic Drug Discovery Platform Variant Bio has launched Inference, the groundbreaking AI-powered genomic drug discovery platform, enhancing pharmaceutical research capabilities globally.

Variant Bio Unveils Inference: A Revolutionary AI Genomic Drug Discovery Platform #USA #Seattle #Drug_Discovery #Variant_Bio #AI_Genomics

AI Data Corporation Revolutionizes R&D with AI-Powered Knowledge Reuse for Drug Discovery AI Data Corporation has unveiled its AI R&D on IDX platform, transforming research knowledge into a valuable asset in drug discovery, enhancing research efficiency.

AI Data Corporation Revolutionizes R&D with AI-Powered Knowledge Reuse for Drug Discovery #Japan #Tokyo #Drug_Discovery #AI_Data_Corporation #AI_R&D

Lunai Bioworks Advances Pharmaceutical Partnerships Amid Market Dynamics Lunai Bioworks, an AI-led pharmaceutical discovery firm, is gaining attention for its strategic partnerships in drug development. A year-end analysis reveals its key role in CNS programs.

Lunai Bioworks Advances Pharmaceutical Partnerships Amid Market Dynamics #United_States #Sacramento #Drug_Discovery #Lunai_Bioworks #AI_pharmaceutical

PRISM BioLab Partners with Talus Bioscience for Groundbreaking Drug Discovery Initiative PRISM BioLab and Talus Bioscience are collaborating to discover novel inhibitors targeting transcription factors and protein-protein interactions, leveraging advanced technologies.

PRISM BioLab Partners with Talus Bioscience for Groundbreaking Drug Discovery Initiative #Japan #Tokyo #Drug_Discovery #PRISM_BioLab #Talus_Bioscience

Utilizing AI in Drug Discovery: Insights and Future Prospects Seminar on January 22, 2026 Join our seminar on January 22, 2026, exploring AI applications in drug discovery. Gain insights from expert Ryosuke Kojima from Kyoto University.

Utilizing AI in Drug Discovery: Insights and Future Prospects Seminar on January 22, 2026 #Japan #AI_Technology #Kyoto #Drug_Discovery #CMC_Research

AI Innovations Revolutionize Biotech and Wellness Technology Landscape Major pharmaceutical firms are leveraging AI to reduce drug discovery timelines significantly, marking a new era in biotech innovation. This trend is boosting wellness tech growth as well.

AI Innovations Revolutionize Biotech and Wellness Technology Landscape #Canada #Ontario #Drug_Discovery #wellness_tech #AI_Models